Expanding Neuromodulation: Clinical Training Guide
With the Canadian neuromodulation market projected to reach C$296.8 million by 2030, the shift toward non-invasive therapies like rTMS is no longer a…
With the Canadian neuromodulation market projected to reach C$296.8 million by 2030, the shift toward non-invasive therapies like rTMS is no longer a…
Novus Medical is the new exclusive distributor for MagVenture TMS. MagVenture is the Danish medical device company behind MagVenture TMS...
In the realm of mental health care, innovation isn’t just about advancing treatment modalities—it’s also about shaping the future of...
© [2020 All Rights Reserved] — Novus Medical Inc.